It has been noted that neurological impairments caused by GAD65-Ab can vary according to epitope specificities.9 In the context of epitope selection, the human leukocyte antigens (HLA) typing of patients with SPS and diabetes mellitus is crucial,10 but success in the HLA predisposition to SPS has so far proved elusive. This evidence concerns the gene GAD2 and diabetes mellitus.